Ming Jen Tan

Dr. Ming Jen Tan

Singapore Centre for 3D Printing (SC3DP), Nanyang Technological University, Singapore 639798, Singapore
orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2017 in Virtual and Physical Prototyping
Verified
Journal Article
Closed access
DTDaniel Yiwei Tay
Daniel Yiwei Tay
BPBiranchi Panda
Biranchi Panda
SUVASH CHANDRA PAULSUVASH CHANDRA PAUL
SUVASH CHANDRA PAUL
NMNisar Ahamed Noor Mohamed
Nisar Ahamed Noor Mohamed
Ming Jen TanMing Jen Tan
Ming Jen Tan
LFLeong Kah Fai
Leong Kah Fai
Three-dimensional (3D) printing (also known as additive manufacturing) is an advanced manufacturing process that can produce complex shape geometries automatically from a 3D computer-aided design model without any tooling, dies and fixtures. This automated manufacturing process has been applied to many diverse fields of industries today due to significant advantages of creating functional prototypes in reasonable build time with less human intervention and minimum material wastage. However, a more recent application of this technology towards the built environment seems to improve our traditional building strategies while reducing the need for human resources, high capital investments and additional formworks. Research interest in employing 3D printing for building and construction has increased exponentially in the past few years. This paper reviews the latest research trends in the discipline by analysing publications from 1997 to 2016. Some recent developments for 3D concrete printing at the Singapore Centre for 3D Printing are also discussed here. Finally, this paper gives a brief description of future work that can be done to improve both the capability and printing quality of the current systems.

1 January 2018 in Archives of Civil and Mechanical Engineering
Verified
Journal Article
Closed access
SUVASH CHANDRA PAULSUVASH CHANDRA PAUL
SUVASH CHANDRA PAUL
DTDaniel Yiwei Tay
Daniel Yiwei Tay
BPBiranchi Panda
Biranchi Panda
Ming Jen TanMing Jen Tan
Ming Jen Tan

1 January 2018 in Measurement
Verified
Journal Article
Closed access
BPBiranchi Panda
Biranchi Panda
SUVASH CHANDRA PAULSUVASH CHANDRA PAUL
SUVASH CHANDRA PAUL
NMNisar Ahamed Noor Mohamed
Nisar Ahamed Noor Mohamed
DTDaniel Yiwei Tay
Daniel Yiwei Tay
Ming Jen TanMing Jen Tan
Ming Jen Tan

21 March 2012 in JAMA
Verified
Journal Article
Open access
PDF file
Ming Jen TanMing Jen Tan
Ming Jen Tan
WWWeizhen Wu
Weizhen Wu
XXXiumin Xu
Xiumin Xu
LLLianming Liao
Lianming Liao
FZFeng Zheng
Feng Zheng
Camillo  RicordiCamillo Ricordi
Camillo Ricordi
Induction therapy, routinely implemented in organ transplant procedures, consists of biologic agents to block early immune activation.1,2 For kidney transplants, lymphodepletion with antithymocyte globulin (ATG) or alemtuzumab has contributed to reducing acute rejection episodes and improving early graft function but remains associated with toxic effects, cytomegalovirus reactivation, and posttransplant lymphoproliferative disease.3-5 Targeting interleukin 2-(IL-2) receptor α chain on activated T lymphocytes can reduce acute rejection episodes in kidney transplant when combined with standard immunosuppression.2


1 November 2017 in Journal of Cleaner Production
Verified
Journal Article
Closed access
BPBiranchi Panda
Biranchi Panda
SUVASH CHANDRA PAULSUVASH CHANDRA PAUL
SUVASH CHANDRA PAUL
LHLim Jian Hui
Lim Jian Hui
DTDaniel Yiwei Tay
Daniel Yiwei Tay
Ming Jen TanMing Jen Tan
Ming Jen Tan